Century Enka Limited (CENTENKA)
Earnings Call Transcript attached.
AI summary
- Q1 FY27 revenue Rs 554 Cr +38% y-y, EBITDA Rs 86 Cr +331% y-y, PAT Rs 62 Cr +301% y-y
- EBITDA margin expanded 1050 bps y-y to 15.46%; PAT margin 11.13%, up 729 bps y-y
- Volume grew 12% y-y to 19,199 MT; tyre cord sales +69%, filament yarn +20%
- Inventory gain of Rs 46.24 Cr boosted profitability; margins expected to normalize
- Renewable power share at 40%, to rise to ~50% post H2 FY27 plant commissioning
- PTCF commercial sales expected to start in H2 FY27
- CAPEX of Rs 100 Cr planned for FY27, focused on value-added products and renewable power
- Normalized EBITDA margin range expected at 7-10%, with potential upside from mix and efficiencies
- Raw material availability stable; sourcing diversified across China, domestic, others
- Capacity utilization steady at 85-90%; new capacity of 3-4k MT to commission in FY28
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 CENTENKA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add CENTENKA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Century Enka Limited
Important.
The summary above is generated automatically from Century Enka Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.